The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Nebulised hypertonic saline solution for acute bronchiolitis in infants
Open accessAbstract
BACKGROUND: Airway oedema (swelling) and mucus plugging are the principal pathological features in infants with acute viral bronchiolitis. Nebulised hypertonic saline solution (≥ 3%) may reduce these pathological changes and decrease airway obstruction. This is an update of a review first published in 2008, and previously updated in 2010 and 2013. OBJECTIVES: To assess the effects of nebulised hypertonic (≥ 3%) saline solution in infants with acute bronchiolitis. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE Daily, Embase, CINAHL, LILACS, and Web of Science on 11 August 2017. We also searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov on 8 April 2017. SELECTION CRITERIA: We included randomised controlled trials and quasi-randomised controlled trials using nebulised hypertonic saline alone or in conjunction with bronchodilators as an active intervention and nebulised 0.9% saline, or standard treatment as a comparator in children under 24 months with acute bronchiolitis. The primary outcome for inpatient trials was length of hospital stay, and the primary outcome for outpatients or emergency department trials was rate of hospitalisation. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, data extraction, and assessment of risk of bias in included studies. We conducted random-effects model meta-analyses using Review Manager 5. We used mean difference (MD), risk ratio (RR), and their 95% confidence intervals (CI) as effect size metrics. MAIN RESULTS: We identified 26 new trials in this update, of which 9 await classification due to insufficient data for eligibility assessment, and 17 trials (N = 3105) met the inclusion criteria. We included a total of 28 trials involving 4195 infants with acute bronchiolitis, of whom 2222 infants received hypertonic saline.Hospitalised infants treated with nebulised hypertonic saline had a statistically significant shorter mean length of hospital stay compared to those treated with nebulised 0.9% saline (MD -0.41 days, 95% CI -0.75 to -0.07; P = 0.02, I² = 79%; 17 trials; 1867 infants) (GRADE quality of evidence: low). Infants who received hypertonic saline also had statistically significant lower post-inhalation clinical scores than infants who received 0.9% saline in the first three days of treatment (day 1: MD -0.77, 95% CI -1.18 to -0.36, P < 0.001; day 2: MD -1.28, 95% CI -1.91 to -0.65, P < 0.001; day 3: MD -1.43, 95% CI -1.82 to -1.04, P < 0.001) (GRADE quality of evidence: low).Nebulised hypertonic saline reduced the risk of hospitalisation by 14% compared with nebulised 0.9% saline among infants who were outpatients and those treated in the emergency department (RR 0.86, 95% CI 0.76 to 0.98; P = 0.02, I² = 7%; 8 trials; 1723 infants) (GRADE quality of evidence: moderate).Twenty-four trials presented safety data: 13 trials (1363 infants, 703 treated with hypertonic saline) did not report any adverse events, and 11 trials (2360 infants, 1265 treated with hypertonic saline) reported at least one adverse event, most of which were mild and resolved spontaneously. AUTHORS' CONCLUSIONS: Nebulised hypertonic saline may modestly reduce length of stay among infants hospitalised with acute bronchiolitis and improve clinical severity score. Treatment with nebulised hypertonic saline may also reduce the risk of hospitalisation among outpatients and emergency department patients. However, we assessed the quality of the evidence as low to moderate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J., Green, S. R., & Higgins, J. (2008) · Cited by 5,544
Systematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
Shay, D. K. (1999) · JAMA · doi:10.1001/jama.282.15.1440 · Cited by 1,385
Chanock, R. M., Kim, H. W., Brandt, C., & Parrott, R. H. (1976) · Viral Infections of Humans · doi:10.1007/978-1-4613-3988-5_17 · Cited by 1,085
Respiratory syncytial virus infection
Simoes, E. A. (1999) · The Lancet · doi:10.1016/s0140-6736(99)80040-3 · Cited by 603
Shay, D. K., Holman, R. C., Roosevelt, G. E., Clarke, M. J., & Anderson, L. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/317655 · Cited by 464
Wang, E. E. L., Milner, R. A., Navas, L., & Maj, H. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.1.106 · Cited by 323
Cited by
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
Ralston, S. L., Lieberthal, A. S., Meissner, H. C., Alverson, B. K., Baley, J. E., Gadomski, A. M., Johnson, D. W., Light, M. J., Maraqa, N. F., Mendonca, E. A., et al. (2014) · Pediatrics · doi:10.1542/peds.2014-2742 · Cited by 1,733
Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology
Tregoning, J. S., & Schwarze, J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-09 · Cited by 747
Glucocorticoids for acute viral bronchiolitis in infants and young children
Fernandes, R. M., Bialy, L. M., Vandermeer, B., Tjosvold, L., Plint, A. C., Patel, H., Johnson, D. W., Klassen, T. P., & Hartling, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004878.pub4 · Cited by 395
Self-citationMazur, N. I., Martinón-Torres, F., Baraldi, E., Fauroux, B., Greenough, A., Heikkinen, T., Manzoni, P., Mejias, A., Nair, H., Papadopoulos, N. G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00255-6 · Cited by 296
Hartling, L., Bialy, L. M., Vandermeer, B., Tjosvold, L., Johnson, D. W., Plint, A. C., Klassen, T. P., Patel, H., & Fernandes, R. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003123.pub3 · Cited by 275
Self-citation
Metadata
- Authors
- Zhang, L., Mendoza-Sassi, R. A., Wainwright, C., & Klassen, T. P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-07-31
- Volume
- 12
- Issue
- 7
- Pages
- CD006458-CD006458
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1976865805
- Cited by
- 353
- References
- 40
- FWCI
- 28.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nebulised hypertonic saline solution for acute bronchiolitis in infants. https://app.cochat.ai/papers/10.1002/14651858.cd006458.pub3
- The paper
- Zhang, L., Mendoza-Sassi, R. A., Wainwright, C., & Klassen, T. P. (2013). Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd006458.pub3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.